Top Markets
Coin of the day
Orum Therapeutics, Inc. Orum Therapeutics, Inc.

Orum Therapeutics, Inc.

475830
Rang in Aktien #9664
Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the... Orum Therapeutics, Inc. is a biopharmaceutical company dedicated to the discovery and development of novel therapeutic solutions for both cancer and immune system conditions. The firm specializes in creating degrader-antibody conjugates, an innovative class of drugs that merges traditional antibody-drug conjugate (ADC) technology with targeted protein degradation. Their flagship product candidate, ORM-1153, functions as a GSPT1 protein degrader, specifically engineered to address hematologic malignancies. Orum Therapeutics was established in 2016 and operates out of Daejeon, South Korea.
Aktienkurs
$45.64
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$969.02M
Veränderung (1 Tag)
-1.20%
Veränderung (1 Jahr)
146.66%
Land
KR
Handel Orum Therapeutics, Inc. (475830)

Kategorie

Dividendenrendite-Verlauf für Orum Therapeutics, Inc. (475830)
Dividendenrendite (TTM) von Orum Therapeutics, Inc. (Aktienkürzel: 475830) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Orum Therapeutics, Inc. (475830) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH